Clinical trials have reported severe hypoglycaemia episodes occurring in 0.7% to 2.4% of patients treated with newer antidiabetic medications (SGLT2 inhibitors, GLP-1 analogues, gliptins) [2]. The gene discussed is SLC5A2; the disease is Hypoglycemia.